| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 07/18/2002 | CA2434152A1 Therapeutic heterocyclic compounds |
| 07/18/2002 | CA2434044A1 1,2-disubstituted cyclic inhibitors of matrix metallorproteases and tnf-alpha |
| 07/18/2002 | CA2434015A1 Therapeutic chroman compounds |
| 07/18/2002 | CA2433950A1 Therapeutic chromone compounds |
| 07/18/2002 | CA2433723A1 Chemical derivatives and their use as anti-telomerase agent |
| 07/18/2002 | CA2432114A1 4-(hetero)aryl substituted indolinones |
| 07/17/2002 | EP1223170A1 Pyrimidine-5-carboxamide compounds, process for producing the same and use thereof |
| 07/17/2002 | EP1223166A1 Linked cyclic polyamines with activity against hiv. |
| 07/17/2002 | EP1222922A1 Method for stabilizing benzimidazole compounds |
| 07/17/2002 | EP1222305A2 Enzymatic process for the resolution of enantiomeric mixtures of beta-lactams |
| 07/17/2002 | EP1222185A1 Tetrahydrobenzindolone derivatives, their preparation and their use as 5-ht7 receptor antagonists |
| 07/17/2002 | EP1222176A1 AMINO LACTAM SULFONAMIDES AS INHIBITORS OF A$g(b) PROTEIN PRODUCTION |
| 07/17/2002 | EP1222175A1 4,5-disubstituted-2-aminopyrimidines |
| 07/17/2002 | EP1222173A1 Process for preparing 4-trifluoromethylsulphinylpyrazole derivative |
| 07/17/2002 | EP1222171A1 Pyridinium derivatives for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof |
| 07/17/2002 | EP1222170A1 Novel nicotinonitrile compounds |
| 07/17/2002 | EP1221953A1 Treating sleep disorders using desloratadine |
| 07/17/2002 | EP1049670B1 Azetidinecarboxamide derivatives for treating cns disorders |
| 07/17/2002 | EP0939629A4 Thiol sulfonamide metalloprotease inhibitors |
| 07/17/2002 | EP0888340B1 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists |
| 07/17/2002 | EP0882044B1 1,4-dihydropyridine compounds as bradykinin antagonists |
| 07/17/2002 | CN1359377A Dihydrobenzodiazepins and their use for treating dyslipidemia |
| 07/17/2002 | CN1359289A Selective iGLuR5 receptor antagonists for the treatment of migraine |
| 07/17/2002 | CN1087741C New indole and inidazole compounds, process for their preparation and pharmaceutical compositions containing them |
| 07/17/2002 | CN1087740C New benzimidzole, benzoxazole and benzothiazole compounds, process for their preparation and pharmaceutical compositions containing them |
| 07/17/2002 | CN1087739C Inclusion and resolution preparation process of optical purity benzimidazoles medicines resisting peptic ulcer |
| 07/17/2002 | CN1087737C Dihygropyridine derivatives as bradykinin ant agonists |
| 07/17/2002 | CN1087736C Novel amidinonaphthyl derivative or salt thereof |
| 07/17/2002 | CN1087735C Process for preparation of pesticidal 1-(haloaryl) heteroyclic compounds |
| 07/16/2002 | US6420975 Interior rearview mirror sound processing system |
| 07/16/2002 | US6420563 Inverse antagonist |
| 07/16/2002 | US6420560 H1—histamine receptor antagonists |
| 07/16/2002 | US6420559 1-(4-arylpiperazin-1-yl)-ω-[N-(α,ω-dicarboximido)]-alkanes useful as uro-selective α1-adrenoceptor blockers |
| 07/16/2002 | US6420558 Aminopiperidine derivates as integrin αvβ3 antagonists |
| 07/16/2002 | US6420557 For therapy of male erectile dysfunction |
| 07/16/2002 | US6420555 Imidazolyl derivatives |
| 07/16/2002 | US6420462 Oxidation resistance, heat resistant and actinic degradationheterocyclic amine oxides |
| 07/16/2002 | US6420438 1-amino-7-isoquinoline derivatives as serine protease inhibitors |
| 07/16/2002 | US6420415 Thiol compounds, their production and use |
| 07/16/2002 | US6420414 Amino derivatives of EM-138 and methods of treating angiogenesis with same |
| 07/16/2002 | US6420409 Benzimidazole derivatives |
| 07/16/2002 | US6420406 Triazolyl disulphides |
| 07/16/2002 | US6420396 Biphenyl and biphenyl-analogous compounds as integrin antagonists |
| 07/16/2002 | US6420395 Disorders or diseases involving the cholinergic system of the central nervous system, pain, inflammatory diseases, diseases caused by smooth muscle contractions and as assistance in the cessation of chemical substance abuse. |
| 07/16/2002 | US6420390 Heteroarylpiperidines and their use as antipsychotics |
| 07/16/2002 | US6420387 Antitumor |
| 07/16/2002 | US6420385 Substituted pyrimidinone and pyridone compounds and methods of use |
| 07/16/2002 | US6420376 Amido spiropiperidines promote the release of growth hormone |
| 07/16/2002 | US6420372 Tropical malarial antiprotozoan |
| 07/16/2002 | US6420371 Angiogenesis inhibitor |
| 07/16/2002 | US6420366 1-(4-arylpiperazin-1-yl)-ω-[N-(αω-dicarboximido)]-alkanes useful as uro-selective α1-adrenoceptor blockers |
| 07/16/2002 | US6420364 Treating autoimmune diseases,alzheimer's disease, atherosclerosis, osteoporosis, |
| 07/16/2002 | US6420315 5-thien-3-yl-2-oxy- or -2-thio-pyridines; high selectivity for broadleaf and grassy weeds in crops, such as maize and rice; pre- and post-emergence |
| 07/16/2002 | CA2240846C Tricyclic amides useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 07/16/2002 | CA2205998C Certain 4-aminomethyl-2-substituted imidazole derivatives and 2-aminomethyl-4-substituted imidazole derivatives; new classes of dopamine receptor subtype specific ligands |
| 07/16/2002 | CA2119511C Benzimidazole compounds, their use and preparation |
| 07/16/2002 | CA2063594C 5-(1-aminocyclohexyl)-2(1h)-pyridinone and related compounds |
| 07/16/2002 | CA2050875C 3-(1h-indazol-3-yl)-4-pyridinamines, a process and intermediates for their preparation and their use as medicaments |
| 07/11/2002 | WO2002053561A1 Excitatory amino acid receptor antagonists |
| 07/11/2002 | WO2002053560A1 Microbiocidal n-phenyl-n-[4-(4-pyridyl-2-pyrimidin-2-yl]-amine derivatives |
| 07/11/2002 | WO2002053559A1 Sodium channel modulators derived from 2-piperidylimidazoles |
| 07/11/2002 | WO2002053558A1 Quinazolone derivatives as alpha 1a/b adrenergic receptor antagonists |
| 07/11/2002 | WO2002053557A1 Novel sulfamides and their use as endothelin receptor antagonists |
| 07/11/2002 | WO2002053556A2 Pyrrolidinylmethyl substituted decahydroisoquinolines as excitatory amino acid receptor antagonists |
| 07/11/2002 | WO2002053555A2 Pyrrolidinylmethyl- and piperidinyl substituted decahydroisoquinolines as excitatory amino acid receptor antagonists |
| 07/11/2002 | WO2002053546A1 Heterocycle derivatives as ppar-gamma agonists |
| 07/11/2002 | WO2002053543A1 Pyridone derivative having affinity for cannabinoid 2-type receptor |
| 07/11/2002 | WO2002053535A2 Process for making amlodipine, derivatives thereof, and precursors therefor |
| 07/11/2002 | WO2002053534A1 Vla-4 inhibitors |
| 07/11/2002 | WO2002053533A2 Kappa opioid receptor ligands |
| 07/11/2002 | WO2002053528A1 Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolines |
| 07/11/2002 | WO2002053516A2 N(phenylsulphonyl)glycine derivatives and their therapeutic use |
| 07/11/2002 | WO2002053155A1 Telomerase inhibitor |
| 07/11/2002 | WO2002053135A1 Amlodipine free base |
| 07/11/2002 | WO2002053097A2 Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination |
| 07/11/2002 | WO2002036734A3 Aza-and polyaza-naphthalenyl ketones useful as hiv integrase inhibitors |
| 07/11/2002 | WO2002024658A3 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists |
| 07/11/2002 | WO2002024657A3 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists |
| 07/11/2002 | WO2002018348A3 Quinazoline derivatives as alpha-1 adrenergic antagonists |
| 07/11/2002 | WO2002008221A3 Capsaicin receptor ligands |
| 07/11/2002 | WO2001040187A3 Compound having effect of promoting neuron differentiation |
| 07/11/2002 | WO2001022919A3 Spiro[bicyclic -azacycloalkyl and -cycloalkyl] derivatives and uses thereof |
| 07/11/2002 | WO2001017568A3 Bioconjugation in vivo to pulmonary or blood components |
| 07/11/2002 | WO2000072834A3 Agent for expression of long-term potentiation of synaptic transmission comprising compound having brain somatostatin activation property |
| 07/11/2002 | US20020091273 Method for the regioselective preparation of substituted benzo[g]quinoline3-carbonitriles and benzo[g]quinazolines |
| 07/11/2002 | US20020091265 4-phenyl-pyridine derivatives |
| 07/11/2002 | US20020091262 Armoatic or heteroarmoatic compound containing substituted amides or thioamides |
| 07/11/2002 | US20020091261 Phthalazines with angiogenesis inhibiting activity |
| 07/11/2002 | US20020091148 3-substituted indole antiproliferative angiogenesis inhibitors |
| 07/11/2002 | US20020091143 Use of 4-substituted tetrahydropyridines for the manufacture of medicament s acting upon TGF-beta 1 |
| 07/11/2002 | US20020091141 Treating serotonin-related central nervous system disorders |
| 07/11/2002 | US20020091138 Treating vascular proliferative disorders |
| 07/11/2002 | US20020091127 Semicarbazides and their uses |
| 07/11/2002 | US20020091124 Also used as an antimitotic and for direct and/or indirect inhibition of tubulin polymerization in mammalian |
| 07/11/2002 | US20020091122 Voltage-dependent |
| 07/11/2002 | US20020091120 2-substituted heterocyclic compounds for treating multidrug resistance |
| 07/11/2002 | US20020091116 Show selectivity for factor Xa versus other proteases of coagulation or the fibrinolytic cascades |
| 07/11/2002 | US20020091090 Somatostatin antagonists and agonists |
| 07/11/2002 | US20020091089 (Substituted)acyl dipeptidyl inhibitors of the ICE/ced-3 family of cysteine proteases |
| 07/11/2002 | US20020091078 Treating diabetes, especially Type II diabetes |